𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade

✍ Scribed by Kurt Redlich; Georg Schett; Günter Steiner; Silvia Hayer; Erwin F. Wagner; Josef S. Smolen

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
711 KB
Volume
48
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis

With concomitant methotrexate. † Pegylated recombinant methionyl human soluble tumor necrosis factor type I.

📜 SIMILAR VOLUMES

Anti–tumor necrosis factor therapy incre
Anti–tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis
✍ Anca Irinel Catrina; Erik af Klint; Sofia Ernestam; Sergiu-Bogdan Catrina; Dimit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## Abstract ## Objective Treatment of rheumatoid arthritis (RA) with tumor necrosis factor (TNF)–blocking agents, including etanercept and infliximab, has resulted in reductions in the radiographic progression of RA. However, the exact mechanism by which this protection occurs has not been determi

Modulation of angiogenic vascular endoth
Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis
✍ Ewa M. Paleolog; Sylvia Young; Alison C. Stark; Richard V. McCloskey; Marc Feldm 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 804 KB

## Objective: To investigate the regulation of expression of the angiogenic cytokine vascular endothelial growth factor (vegf) in rheumatoid arthritis (ra), in order to determine whether new blood vessel formation could be a potential therapeutic target in ra. ## Methods: Dissociated ra synovial